Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease

• Asıl Yazarlar: N. A. Shatalova (Yazar), D. A. Sychev (Yazar), K. B. Mirzaev (Yazar), A. I. Kochetkov (Yazar), E. Yu. Ebzeeva (Yazar), V. B. Dashabylova (Yazar), P. O. Bochkov (Yazar), S. N. Tuchkova (Yazar), S. V. Glagolev (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Столичная издательская компания, 2023-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Aim. To study the possible relationship between polymorphic variants of ABCB1 (rs2032582, rs1045642, rs1128503), CYP3A5 (rs776746), CYP3A4 (rs35599367) and CYP2J2 (rs890293) genes with residual equilibrium concentrations (Cmin,ss) of rivaroxaban in patients with non-valvular atrial fibrillation (AF)...